Loading...
XSWXAEVS
Market cap1.29bUSD
Dec 20, Last price  
13.70CHF
1D
-2.14%
1Q
-2.14%
Jan 2017
7.03%
Name

Aevis Victoria SA

Chart & Performance

D1W1MN
XSWX:AEVS chart
P/E
—
P/S
1.26
EPS
—
Div Yield, %
5.48%
Shrs. gr., 5y
1.22%
Rev. gr., 5y
9.64%
Revenues
914m
-11.27%
9,555,000120,073,000119,135,000128,834,000181,485,000200,818,000344,406,000454,669,000484,852,000508,093,000517,115,000582,505,000577,130,000697,234,000696,566,000823,256,0001,030,550,000914,363,000
Net income
-39m
L
-30,867,700-3,232,000164,0001,945,000-7,123,000471,0003,325,0008,675,0006,118,0003,770,0002,309,000-922,000-8,659,000163,195,000-31,795,000-4,265,00058,812,000-39,295,000
CFO
43m
-62.67%
846,0005,568,00010,508,0008,990,00013,601,00012,684,00013,136,00041,674,00018,631,00036,575,00055,600,00060,094,00016,387,00018,862,00023,770,00033,534,000114,300,00042,673,000
Dividend
Sep 28, 20230.3 CHF/sh
Earnings
Apr 03, 2025

Profile

Aevis Victoria SA engages in healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. The company operates through Hospitals, Hospitality, Telemedicine, and Real Estate segments. It operates 22 hospitals with 1,496 beds; manages with a total of 941 rooms with a total rentable surface of 188,109 sqm. It also provides telemedicine, and ambulance and day clinic services. In addition, it engages in the patient hotel, better aging, radiology institute, pharmacy, ophthalmology, real estate management, stem cells, cosmetics, and publishing businesses, as well as organizes seminars. The company is headquartered in Fribourg, Switzerland. Aevis Victoria SA is a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
URL
https://www.aevis.com/
IPO date
Jul 05, 1999
Employees
3,902
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
914,363
-11.27%
1,030,550
25.18%
823,256
18.19%
Cost of revenue
787,741
1,016,084
838,040
Unusual Expense (Income)
NOPBT
126,622
14,466
(14,784)
NOPBT Margin
13.85%
1.40%
Operating Taxes
(1,699)
4,679
818
Tax Rate
32.34%
NOPAT
128,321
9,787
(15,602)
Net income
(39,295)
-166.81%
58,812
-1,478.94%
(4,265)
-86.59%
Dividends
(63,185)
(84,416)
Dividend yield
Proceeds from repurchase of equity
(4,007)
95,561
(1,914)
BB yield
Debt
Debt current
116,386
86,644
302,967
Long-term debt
906,265
883,391
538,300
Deferred revenue
(61,114)
11,337
16,287
Other long-term liabilities
600
2,827
6,918
Net debt
698,984
642,375
583,519
Cash flow
Cash from operating activities
42,673
114,300
33,534
CAPEX
(86,451)
(74,019)
(57,599)
Cash from investing activities
35,564
(56,817)
21,631
Cash from financing activities
(72,953)
(45,456)
(57,306)
FCF
88,040
24,786
(195,989)
Balance
Cash
80,706
75,427
63,418
Long term investments
242,961
252,233
194,330
Excess cash
277,949
276,132
216,585
Stockholders' equity
543,365
512,187
589,135
Invested Capital
1,262,722
1,205,044
1,204,090
ROIC
10.40%
0.81%
ROCE
7.91%
0.94%
EV
Common stock shares outstanding
84,340
85,512
83,800
Price
Market cap
EV
EBITDA
188,559
81,056
46,887
EV/EBITDA
Interest
35,072
25,382
21,812
Interest/NOPBT
27.70%
175.46%